146 related articles for article (PubMed ID: 31267364)
1. Peptidyl Arginine Deiminase, Type II (PADI2) Is Involved in Urothelial Bladder Cancer.
Gao BS; Rong CS; Xu HM; Sun T; Hou J; Xu Y
Pathol Oncol Res; 2020 Apr; 26(2):1279-1285. PubMed ID: 31267364
[TBL] [Abstract][Full Text] [Related]
2. The impact of the receptor of hyaluronan-mediated motility (RHAMM) on human urothelial transitional cell cancer of the bladder.
Niedworok C; Kretschmer I; Röck K; Vom Dorp F; Szarvas T; Heß J; Freudenberger T; Melchior-Becker A; Rübben H; Fischer JW
PLoS One; 2013; 8(9):e75681. PubMed ID: 24069434
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of PADI2 prevents proliferation and epithelial-mesenchymal transition in ovarian cancer through inhibiting JAK2/STAT3 pathway in vitro and in vivo, alone or in combination with Olaparib.
Liu L; Zhang Z; Zhang G; Wang T; Ma Y; Guo W
J Transl Med; 2020 Sep; 18(1):357. PubMed ID: 32951601
[TBL] [Abstract][Full Text] [Related]
4. Identification of PADI2 as a potential breast cancer biomarker and therapeutic target.
McElwee JL; Mohanan S; Griffith OL; Breuer HC; Anguish LJ; Cherrington BD; Palmer AM; Howe LR; Subramanian V; Causey CP; Thompson PR; Gray JW; Coonrod SA
BMC Cancer; 2012 Oct; 12():500. PubMed ID: 23110523
[TBL] [Abstract][Full Text] [Related]
5. Protein-arginine deiminase 2 suppresses proliferation of colon cancer cells through protein citrullination.
Funayama R; Taniguchi H; Mizuma M; Fujishima F; Kobayashi M; Ohnuma S; Unno M; Nakayama K
Cancer Sci; 2017 Apr; 108(4):713-718. PubMed ID: 28403548
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic silencing of the dual-role signal mediator, ANGPTL4 in tumor tissues and its overexpression in the urothelial carcinoma microenvironment.
Hsieh HY; Jou YC; Tung CL; Tsai YS; Wang YH; Chi CL; Lin RI; Hung SK; Chuang YM; Wu SF; Li C; Shen CH; Chan MWY; Hsu CD
Oncogene; 2018 Feb; 37(5):673-686. PubMed ID: 29035390
[TBL] [Abstract][Full Text] [Related]
7. ZKSCAN3 promotes bladder cancer cell proliferation, migration, and invasion.
Kawahara T; Inoue S; Ide H; Kashiwagi E; Ohtake S; Mizushima T; Li P; Li Y; Zheng Y; Uemura H; Netto GJ; Ishiguro H; Miyamoto H
Oncotarget; 2016 Aug; 7(33):53599-53610. PubMed ID: 27447553
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-30a as a prognostic factor in urothelial carcinoma of bladder inhibits cellular malignancy by antagonising Notch1.
Zhang C; Ma X; Du J; Yao Z; Shi T; Ai Q; Chen X; Zhang Z; Zhang X; Yao X
BJU Int; 2016 Oct; 118(4):578-89. PubMed ID: 26775686
[TBL] [Abstract][Full Text] [Related]
9. ROS-induced PADI2 downregulation accelerates cellular senescence via the stimulation of SASP production and NFκB activation.
Kim HJ; Kim WJ; Shin HR; Yoon HI; Moon JI; Lee E; Lim JM; Cho YD; Lee MH; Kim HG; Ryoo HM
Cell Mol Life Sci; 2022 Feb; 79(3):155. PubMed ID: 35218410
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of TRAG3 gene in urothelial carcinoma of the bladder.
Karam JA; Huang S; Fan J; Stanfield J; Schultz RA; Pong RC; Sun X; Mason RP; Xie XJ; Niu G; Chen X; Frenkel EP; Sagalowsky AI; Hsieh JT
Int J Cancer; 2011 Jun; 128(12):2823-32. PubMed ID: 20734393
[TBL] [Abstract][Full Text] [Related]
11. Expression of Med19 in bladder cancer tissues and its role on bladder cancer cell growth.
Zhang H; Jiang H; Wang W; Gong J; Zhang L; Chen Z; Ding Q
Urol Oncol; 2012; 30(6):920-7. PubMed ID: 21478038
[TBL] [Abstract][Full Text] [Related]
12. Inducing cell proliferation inhibition and apoptosis via silencing Dicer, Drosha, and Exportin 5 in urothelial carcinoma of the bladder.
Han Y; Liu Y; Gui Y; Cai Z
J Surg Oncol; 2013 Feb; 107(2):201-5. PubMed ID: 22766726
[TBL] [Abstract][Full Text] [Related]
13. Cell-Intrinsic Tumorigenic Functions of PPARγ in Bladder Urothelial Carcinoma.
Sanchez DJ; Missiaen R; Skuli N; Steger DJ; Simon MC
Mol Cancer Res; 2021 Apr; 19(4):598-611. PubMed ID: 33431608
[TBL] [Abstract][Full Text] [Related]
14. Repression of engrailed 2 inhibits the proliferation and invasion of human bladder cancer in vitro and in vivo.
Li Y; Liu H; Lai C; Su Z; Heng B; Gao S
Oncol Rep; 2015 May; 33(5):2319-30. PubMed ID: 25812440
[TBL] [Abstract][Full Text] [Related]
15. The Clinical and Prognostic Significance of Protein Arginine Deiminases 2 and 4 in Colorectal Cancer.
Gijon M; Metheringham RL; Toss MS; Paston SJ; Durrant LG
Pathobiology; 2022; 89(1):38-48. PubMed ID: 34569542
[TBL] [Abstract][Full Text] [Related]
16. The Essential Role of Peptidylarginine Deiminases 2 for Cytokines Secretion, Apoptosis, and Cell Adhesion in Macrophage.
Yu HC; Tung CH; Huang KY; Huang HB; Lu MC
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32785008
[TBL] [Abstract][Full Text] [Related]
17. High expression of polo-like kinase 1 is associated with the metastasis and recurrence in urothelial carcinoma of bladder.
Zhang Z; Zhang G; Kong C
Urol Oncol; 2013 Oct; 31(7):1222-30. PubMed ID: 22192978
[TBL] [Abstract][Full Text] [Related]
18. SLC14A1 prevents oncometabolite accumulation and recruits HDAC1 to transrepress oncometabolite genes in urothelial carcinoma.
Chan TC; Wu WJ; Li WM; Shiao MS; Shiue YL; Li CF
Theranostics; 2020; 10(25):11775-11793. PubMed ID: 33052246
[TBL] [Abstract][Full Text] [Related]
19. Regulator of cullins-1 expression knockdown suppresses the malignant progression of muscle-invasive transitional cell carcinoma by regulating mTOR/DEPTOR pathway.
Wang W; Chen H; Liu Z; Qu P; Lan J; Chen H; Zou L; Qiu J
Br J Cancer; 2016 Feb; 114(3):305-13. PubMed ID: 26742010
[TBL] [Abstract][Full Text] [Related]
20. Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer.
Juanpere N; Agell L; Lorenzo M; de Muga S; López-Vilaró L; Murillo R; Mojal S; Serrano S; Lorente JA; Lloreta J; Hernández S
Hum Pathol; 2012 Oct; 43(10):1573-82. PubMed ID: 22417847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
